Skip to main content
Figure 1 | BMC Psychiatry

Figure 1

From: Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial

Figure 1

Subject Randomization. Of 652 subjects enrolled in the double-blind treatment period, 488 were randomized (1:1:1:1) to paliperidone palmitate (fixed dose of 39, 156, or 234 mg) and 164 to placebo. All those randomized to the fixed doses of paliperidone palmitate received 234 mg as the first initiation dose on Day 1, followed by administration of their fixed dose on Days 8, 36, and 64.

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us